Tilson: AIG Is No V...
Health Care: Drugs
Infinity Pharmaceuticals Inc. (INFI: NASDAQ)
$24.91 0.59 | 2.43%
05/17/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 175.74M | 24.20M | 20.42M | 16.29M |
| Receivables | 0.00 | 218.19K | 35.06K | 55.06K |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 329.75M | 117.98M | 103.13M | 133.61M |
| Property, Plant & Equipment, Gross | 27.45M | 27.29M | 26.27M | 24.63M |
| Accumulated Depreciation & Depletion | 23.37M | 22.71M | 21.12M | 18.94M |
| Property, Plant & Equipment, Net | 4.08M | 4.58M | 5.15M | 5.69M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 1.83M | 1.93M | 16.29M | 18.01M |
| Total Non-Current Assets | 5.91M | 6.51M | 21.44M | 23.70M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 335.66M | 124.49M | 124.57M | 157.32M |
| Accounts Payable | 8.60M | 5.95M | 2.61M | 1.44M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 6.46K |
| Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Liabilities | 18.66M | 28.99M | 27.75M | 12.98M |
| Long Term Debt | 0.00 | 37.55M | 0.00 | 0.00 |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 6.79M | 42.52M | 47.33M | 38.07M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 6.79M | 80.07M | 47.33M | 38.08M |
| Total Liabilities | 25.46M | 109.06M | 75.08M | 51.06M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 310.20M | 15.43M | 49.48M | 106.26M |
| Common Par | 48.00K | 26.72K | 26.52K | 26.24K |
| Additional Paid In Capital | 633.04M | 284.44M | 278.41M | 287.59M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -323.02M | -269.05M | -229.01M | -181.40M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 134.00K | 22.42K | 53.98K | 37.29K |
| Total Capitalization | 310.20M | 52.99M | 49.48M | 106.26M |
| Total Equity | 310.20M | 15.43M | 49.48M | 106.26M |
| Total Liabilities & Stock Equity | 335.66M | 124.49M | 124.57M | 157.32M |
| Total Common Shares Outstanding | 47.50M | 26.72M | 26.52M | 26.24M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 31.71M | 26.62M | 26.32M | 26.10M |
| Diluted Weighted Shares Outstanding | 31.71M | 26.62M | 26.32M | 26.10M |
| Number of Employees | 154 | 190 | 168 | 179 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with INFI
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Rising On Unusual Vo...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Under-$10 Moving Hig...
- Contributor8 Health Care Stocks With R...
Latest INFI Headlines from TheStreet
- Quick Take: The Next Big Thing in Biotech 05.17.13 | 10:05 am
- Biotech's Next Big Thing ASCO II
05.16.13 | 02:05 pm - Infinity Pharmaceuticals (INFI) Shares Cross Below 200 DMA 05.16.13 | 11:05 am
- ASCO '13 Preview: Gilead's Big Cancer Debut 05.15.13 | 06:05 pm
- 10 ASCO '13 Abstracts You Can Read Right Now 05.15.13 | 06:05 pm
- Biotech's Next Big Thing: ASCO 05.09.13 | 09:05 am
- Infinity Pharmaceuticals Enters Oversold Territory (INFI) 05.08.13 | 12:05 pm
- Top Insider Trades: NAV, TXI, INFI, AGCO 04.17.13 | 09:04 am
- Most Profitable Second Quarter Biotech Stocks 04.02.13 | 06:04 am
- 7 Biotechnology Stocks With Insider Buying Activity 03.20.13 | 10:03 am
Press Releases for INFI
- Infinity To Present At The 25th Annual Roth Conference - Business Wire 03.11.13 | 08:03 am
- Infinity Provides Company Update And Reports Full-Year 2012 Financial Results - Business Wire 03.05.13 | 04:03 pm
- Infinity To Present At Upcoming Conferences - Business Wire 02.25.13 | 08:02 am
- Infinity Announces The Date Of Its Full-Year 2012 Financial Results Conference Call And Webcast - Business Wire 02.19.13 | 08:02 am
- Infinity To Participate In Three Conferences In February - Business Wire 02.06.13 | 08:02 am
- Infinity Provides Key 2013 Goals And Financial Guidance - Business Wire 01.07.13 | 08:01 am
- Infinity To Present At The J.P. Morgan Annual Healthcare Conference - Business Wire 12.31.12 | 08:12 am
- Infinity Amends PI3K-Delta,Gamma Agreement With Millennium - Business Wire 12.24.12 | 08:12 am
- Infinity Announces Closing Of Public Offering And Exercise Of Over-Allotment Option - Business Wire 12.18.12 | 10:12 am
- Infinity Prices Public Offering Of Common Stock - Business Wire 12.13.12 | 09:12 am
Partner Headlines for INFI
- Pre-Market Most Active for Apr 11, 2013 : PCS, RAD, SGYP, INFI, MSFT, ACAD, RLGY, QQQ, FTNT, NOK, BAC, HPQ - NASDAQ 04.11.13 | 12:04 pm
- These Stocks Are On Winning Streaks, But Short Sellers Aren't Optimistic - Seeking Alpha 01.09.13 | 09:01 am
- Infinity Pharma RESTRUCTURES Alliance with Mundipharma and 4 Stocks Hiting 52-Week Highs - Wall St. Cheat Sheet 07.19.12 | 09:07 am
- Morning Market Losers - Benzinga 06.18.12 | 09:06 am
- Ultimate Market Recap: Body Central Sinks 47%, Facebook Buys Face.com - Wall St. Cheat Sheet 06.18.12 | 08:06 am
- Body Central CRASHES 47% and 4 Hot Stocks in the Crosshairs - Wall St. Cheat Sheet 06.18.12 | 03:06 am
- Noteworthy Institutional 5% Ownership Filings On Friday - Seeking Alpha 04.02.12 | 08:04 am
- AACR Annual Oncology Meeting: A Look Into Various Abstracts - Seeking Alpha 03.27.12 | 09:03 am
- Earnings Expectations for the Week of March 12 (URBN, ROST) - Benzinga 03.11.12 | 11:03 am
- Company News for January 30, 2012 - Corporate Summary - Zacks 01.30.12 | 10:01 am
